Berberine

Typical form: Berberine HCl

Recommended tests

Triglycerides & hs-CRP

Berberine is used here for two different markers at once: triglycerides (a metabolic/lipid marker) and hs-CRP (an inflammation marker). Both respond to the same underlying mechanism — berberine activates AMPK, a cellular energy-regulation switch that improves glucose and lipid handling while also calming inflammatory signaling.

Interpret all results with a healthcare provider — triglycerides and hs-CRP are often used as proxies for overall metabolic and cellular function rather than treated as isolated numbers; the pattern across both, alongside other markers, matters more than either one alone.

Common form & typical benefits

Berberine HCl

The standard, most-studied form used in clinical trials for glucose, lipid, and inflammation outcomes
Works primarily through activating AMPK — the same "metabolic switch" activated by exercise and by the drug metformin
Best absorbed and most effective when taken with meals, since it's metabolized alongside the glucose/lipid spike from eating

Research noteA meta-analysis of 11 RCTs (874 people) found berberine reduced total cholesterol, triglycerides, and LDL, with a modest HDL increase. A larger, more recent meta-analysis (52 studies, 4,616 people with metabolic syndrome or related conditions) found significant reductions in CRP, TNF-alpha, and IL-6. A separate CRP-focused meta-analysis of 5 trials found a consistent reduction with no significant heterogeneity between studies — a sign the effect is fairly reproducible across different trial populations.

What the research says

Evidence by outcome

Outcome	Approx. evidence base	Typical finding
Triglycerides	Meta-analysis, 11 RCTs (874 people)	Meaningful reduction (~0.50 mmol/L average)
Total & LDL cholesterol	Same meta-analysis	Significant reductions in both
hs-CRP / inflammation	Meta-analysis, 52 studies (4,616 people)	Significant reductions in CRP, TNF-alpha, and IL-6
CRP specifically (focused analysis)	5 RCTs	Consistent reduction, low variability between studies
Fasting glucose & waist circumference	Meta-analysis, metabolic syndrome patients	Modest but significant improvements in both

Research summary chart

View PDF ↗

Dosages used in studies

What the research actually tested

Goal	Typical dose	Notes	Duration
Practitioner-used dose (this site)	~1,500 mg/day, split into 3 doses	Taken with meals	Ongoing, per practitioner
Lipids / triglycerides (research range)	900–1,500 mg/day, split into 3 doses	Taken with meals	8–12+ weeks
Inflammation, CRP (research range)	500 mg, 2–3x/day	Standard clinical trial dosing strength	8–12 weeks
General/full clinical range (research)	900–2,000 mg/day total	Split into 3-4 doses due to short half-life	Ongoing, per practitioner

Safety notes & high-dose risks

What to watch for

GI side effects are the most common issue — diarrhea, constipation, gas, and stomach pain, especially at doses above 300 mg/day. Starting at a lower dose and building up helps.
Hypoglycemia risk: berberine lowers blood sugar through a similar mechanism to metformin — combining the two, or combining berberine with other glucose-lowering medications, can have an additive effect and needs medical supervision.
Drug interactions: berberine inhibits several liver enzymes involved in drug metabolism (CYP450 pathways), which can affect how other medications are processed — this is a meaningful interaction risk for anyone on regular prescription medication, not a minor footnote.
Contraindicated in pregnancy and breastfeeding.
No serious adverse events have been reported across the meta-analyses reviewed here, but most trials run 8-12 weeks — long-term safety data beyond that window is more limited.

Additional notes

Worth knowing

Timing: take with meals — this is when it's most effective, since it's acting on the glucose/lipid response to food.
Short half-life: this is why studies typically split the daily dose into 2-4 smaller doses rather than one large one.
Why it's used for two markers at once: the same AMPK-activation mechanism that lowers triglycerides also reduces inflammatory signaling — this is a case where one supplement genuinely addresses two markers through one shared pathway, rather than needing separate products for each.
Retesting: triglycerides and hs-CRP roughly 8-12 weeks after starting is a reasonable check-in point.
More is not better: going beyond the standard clinical dosing range mainly increases GI side effects without added benefit.

Shop on Fullscript Shop on Prodrome

Educational information only — not medical advice. Lab testing and any supplementation decisions should be made with a qualified healthcare provider who knows your personal health history. Research findings vary by population, dose, form, and study quality.

Some links go to Fullscript, where I may earn a commission at no extra cost to you. I only recommend supplements I've either used myself or seen work in my clients' lab data. Results vary from person to person.